Phase II single-arm trial of TKM Ebola Guinea in patients with Ebola virus infections in Sierra Leone.

Trial Profile

Phase II single-arm trial of TKM Ebola Guinea in patients with Ebola virus infections in Sierra Leone.

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 19 Jun 2015

At a glance

  • Drugs TKM-Ebola-Guinea (Primary)
  • Indications Ebola virus infections
  • Focus Therapeutic Use
  • Acronyms RAPIDE
  • Most Recent Events

    • 19 Jun 2015 According to Tekmira Pharmaceuticals media release, data analysis is ongoing and the full results will be made available as soon as possible.
    • 19 Jun 2015 Status changed from recruiting to active, no longer recruiting; as reported in Tekmira Pharmaceuticals media release.
    • 13 Mar 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top